Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 204819

Expand all

ADEMPAS (RIOCIGUAT)
0.5MG Marketing Status: Prescription

Active Ingredient: RIOCIGUAT
Proprietary Name: ADEMPAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N204819
Product Number: 001
Approval Date: Oct 8, 2013
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ADEMPAS (RIOCIGUAT)
1MG Marketing Status: Prescription

Active Ingredient: RIOCIGUAT
Proprietary Name: ADEMPAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N204819
Product Number: 002
Approval Date: Oct 8, 2013
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ADEMPAS (RIOCIGUAT)
1.5MG Marketing Status: Prescription

Active Ingredient: RIOCIGUAT
Proprietary Name: ADEMPAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N204819
Product Number: 003
Approval Date: Oct 8, 2013
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ADEMPAS (RIOCIGUAT)
2MG Marketing Status: Prescription

Active Ingredient: RIOCIGUAT
Proprietary Name: ADEMPAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N204819
Product Number: 004
Approval Date: Oct 8, 2013
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ADEMPAS (RIOCIGUAT)
2.5MG Marketing Status: Prescription

Active Ingredient: RIOCIGUAT
Proprietary Name: ADEMPAS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N204819
Product Number: 005
Approval Date: Oct 8, 2013
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English